Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 229 (1) , 127-134
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Subcellular Localization and Tumor-suppressive Functions of 15-Lipoxygenase 2 (15-LOX2) and Its Splice VariantsJournal of Biological Chemistry, 2003
- Mammalian arachidonate 15-lipoxygenasesProstaglandins & Other Lipid Mediators, 2002
- Interleukin (IL)-4 Indirectly Suppresses IL-2 Production by Human T Lymphocytes via Peroxisome Proliferator-activated Receptor γ Activated by Macrophage-derived 12/15-Lipoxygenase LigandsJournal of Biological Chemistry, 2002
- Lipoxygenases and their involvement in programmed cell deathCell Death & Differentiation, 2001
- Tissue-specific gene therapy directed to tumor angiogenesisGene Therapy, 2001
- Induction of 15-Lipoxygenase mRNA and Protein in Early Atherosclerotic LesionsCirculation, 1995
- Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter.Journal of Clinical Investigation, 1995
- Vascular lipoxygenase activity: synthesis of 15-hydroxyeicosatetraenoic acid from arachidonic acid by blood vessels and cultured vascular endothelial cellsThrombosis Research, 1987
- Evidence for 15-HETE synthesis by human umbilical vein endothelial cells.Circulation, 1985
- A lipoxygenase in rabbit reticulocytes which attacks phospholipids and intact mitochondriaFEBS Letters, 1975